Author: admin

The pharmaceutical landscape is shifting. It’s no longer just about developing groundbreaking therapies; it’s about ensuring those therapies reach the right patients, at the right time, and that those patients are empowered throughout their journey. Traditional methods of patient recruitment and engagement – relying heavily on clinician referrals and broad-stroke awareness campaigns – are often…

In today’s increasingly complex pharmaceutical landscape, companies are constantly seeking ways to optimize their market presence and maintain competitive pricing. One often overlooked opportunity in the European Union is parallel importing – a legitimate practice that can offer significant benefits to various stakeholders in the pharmaceutical supply chain. What is Parallel Importing? Parallel importing in…

France is home to one of Europe’s most dynamic pharmaceutical and biotechnology ecosystems, making it a prime location for Contract Research Organizations (CROs). With a robust infrastructure, a commitment to innovation, and a strong regulatory framework, France has emerged as a strategic choice for companies seeking comprehensive research support. Below, we delve into what makes…

Expanding into Europe is a milestone for many pharmaceutical companies, offering access to one of the world’s largest healthcare markets. However, Europe is not a single, homogenous entity—it’s a patchwork of countries, each with unique regulatory requirements, pricing strategies, and market opportunities. A well-planned, localized approach is critical to succeed. Here’s a breakdown of some…